Objectives: The presentation deals with the dental product platform of the Ca-aluminate based biomaterials (CA). Nanostructures including nanocrystals and nanoporosity are easily formed in the CA-system due to a low solubility product of the phases formed. The crystal size is < 50 nm and the nano-channels surrounding all nanocrystals < 3 nm in width. Methods: The CA materials were synthesized by Doxa AB. Jet-milling was used to obtain fine-grained original particles. Added phases were glasses or ZrO2 depending on the intended applications. For early hardening, a glass ionomer was used. The nanostructures were studied using HRTEM in combination with focused ion beam microscopy (FIB) for site-specific accuracy preparation. Mechanical testing included flexural strength, compressive strength, Youngxs modulus and fracture toughness. Results: The nanostructures contribute to high mechanical strength, and complete sealing of contact zones to surrounding materials. Practically related properties deal with 1) Nanostructural integration with reduced risk of secondary caries and restoration failure, 2) Reduced post-operative sensitivity, 3) Environmental friendliness, and no allergy, 4) Consistency and setting properties suitable for the intended applications with reliable clinical handling performance, 5) No extra bonding, 6) No dry field precaution – moisture-tolerant, 7) Excellent retention, 8) No shrinkage and 9) Longevity. The CA-based biomaterials are close in chemistry to apatite, and the thermal and electrical properties are close to those of hard tissue. Conclusions: Ten dental products have been identified based on material data, pre-clinical and pilot studies, and on-going clinical studies; Dental cements, endodontics, sealants, bases, restoratives, stabilising materials and pastes for augmentation, and as coating materials. Properties related to nanostructures give the CA-based materials potential also as carriers for medicaments with unique ways of loading possibilities and controlling of the release rate. Supported by Doxa AB, Sweden.